PACIRA BIOSCIENCES INC (PCRX) Stock Earnings & Estimates
USA - NASDAQ:PCRX - US6951271005 - Common Stock
24.12 USD
+0.24 (+1.01%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 666.8M 23.14% | 674.978M 1.23% | 700.966M 3.85% | 751.94M 7.27% | 828.49M 10.18% | 901.23M 8.78% | 949.06M 5.31% | 930.34M -1.97% | 879.04M -5.51% | 985.83M 12.15% | 819.57M -16.86% | |
| EBITDA YoY % growth | 162.4M 0.68% | 166.321M 2.41% | 180.816M 8.72% | 205.77M 13.80% | 232.77M 13.12% | 257.24M 10.51% | 277.13M 7.73% | 286.01M 3.20% | 262.34M -8.28% | N/A | N/A | |
| EBIT YoY % growth | 70.9M -46.61% | 90.747M 27.99% | 102.031M 12.43% | 149.38M 46.41% | 177.61M 18.90% | 209.2M 17.79% | 273M 30.50% | 258.67M -5.25% | 234.7M -9.27% | 390.9M 66.55% | 242.12M -38.06% | |
| Operating Margin | 10.63% | 13.44% | 14.56% | 19.87% | 21.44% | 23.21% | 28.77% | 27.80% | 26.70% | 39.65% | 29.54% | |
| EPS YoY % growth | 2.59 -13.38% | 2.92 12.74% | 3.21 9.93% | 2.93 -8.75% | 3.31 13.10% | 3.83 15.46% | 4.23 10.57% | 4.28 1.16% | 4.24 -0.95% | 5.42 27.80% | 3.13 -42.18% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.90 -1.36% | 0.83 33.26% | 0.80 7.51% | 0.86 22.40% | 0.89 -1.14% |
| Revenue Q2Q % growth | 207.86M 11.00% | 195.29M 15.61% | 206.44M 13.99% | 213.95M 19.18% | 220.41M 6.04% |
| EBITDA Q2Q % growth | 60.361M -43.71% | 51.661M 61.34% | 56.972M -3.57% | 60.682M -27.25% | 63.408M 5.05% |
| EBIT Q2Q % growth | 56.338M 98.02% | 13.255M 22.14% | 18.483M 74.53% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.70 -11.39% | 0.66 | 0.04 | 5.28% |
| Q2 2025 Q2Q % growth | 0.74 -16.85% | 0.72 | 0.02 | 2.13% |
| Q1 2025 Q2Q % growth | 0.62 | 0.61 | 0.01 | 1.99% |
| Q4 2024 Q2Q % growth | 0.91 2.25% | 0.85 | 0.06 | 6.81% |
| Q3 2024 Q2Q % growth | 0.79 9.72% | 0.72 | 0.07 | 9.93% |
| Q2 2024 Q2Q % growth | 0.89 14.10% | 0.71 | 0.18 | 24.81% |
| Q1 2024 Q2Q % growth | 0.62 16.98% | 0.64 | -0.02 | -2.59% |
| Q4 2023 Q2Q % growth | 0.89 11.25% | 0.90 | -0.01 | -1.23% |
| Q3 2023 Q2Q % growth | 0.72 12.50% | 0.80 | -0.08 | -9.96% |
| Q2 2023 Q2Q % growth | 0.78 52.94% | 0.77 | 0.01 | 0.88% |
| Q1 2023 Q2Q % growth | 0.53 -17.19% | 0.63 | -0.10 | -15.78% |
| Q4 2022 Q2Q % growth | 0.80 -17.53% | 0.85 | -0.05 | -5.48% |
| Q3 2022 Q2Q % growth | 0.64 -11.11% | 0.78 | -0.14 | -17.87% |
| Q2 2022 Q2Q % growth | 0.51 -33.77% | 0.87 | -0.36 | -41.29% |
| Q1 2022 Q2Q % growth | 0.64 20.75% | 0.85 | -0.21 | -24.60% |
| Q4 2021 Q2Q % growth | 0.97 11.49% | 0.92 | 0.05 | 5.31% |
| Q3 2021 Q2Q % growth | 0.72 5.88% | 0.67 | 0.05 | 8.04% |
| Q2 2021 Q2Q % growth | 0.77 541.67% | 0.75 | 0.02 | 2.59% |
| Q1 2021 Q2Q % growth | 0.53 | 0.65 | -0.12 | -18.19% |
| Q4 2020 Q2Q % growth | 0.87 55.36% | 0.84 | 0.03 | 3.48% |
| Q3 2020 Q2Q % growth | 0.68 41.67% | 0.64 | 0.04 | 5.69% |
| Q2 2020 Q2Q % growth | 0.12 -70.73% | 0.09 | 0.03 | 26.79% |
| Q1 2020 Q2Q % growth | 0.53 140.91% | 0.30 | 0.23 | 74.37% |
| Q4 2019 Q2Q % growth | 0.56 | 0.45 | 0.11 | 25.20% |
| Q3 2019 Q2Q % growth | 0.48 | 0.33 | 0.15 | 44.41% |
| Q2 2019 Q2Q % growth | 0.41 | 0.35 | 0.06 | 16.17% |
| Q1 2019 Q2Q % growth | 0.22 | 0.27 | -0.05 | -17.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 179.516M 6.49% | 186.2M | -6.684M | -3.59% |
| Q2 2025 Q2Q % growth | 181.099M 1.73% | 186.69M | -5.591M | -2.99% |
| Q1 2025 Q2Q % growth | 168.923M 1.08% | 179.55M | -10.627M | -5.92% |
| Q4 2024 Q2Q % growth | 187.253M 3.32% | 188.05M | -797K | -0.42% |
| Q3 2024 Q2Q % growth | 168.573M 2.83% | 173.07M | -4.497M | -2.60% |
| Q2 2024 Q2Q % growth | 178.023M 5.05% | 175.95M | 2.073M | 1.18% |
| Q1 2024 Q2Q % growth | 167.117M 4.23% | 168.11M | -993K | -0.59% |
| Q4 2023 Q2Q % growth | 181.244M 5.37% | 185.3M | -4.056M | -2.19% |
| Q3 2023 Q2Q % growth | 163.926M -2.13% | 175.06M | -11.134M | -6.36% |
| Q2 2023 Q2Q % growth | 169.467M 0.04% | 178.1M | -8.633M | -4.85% |
| Q1 2023 Q2Q % growth | 160.341M 1.48% | 162.02M | -1.679M | -1.04% |
| Q4 2022 Q2Q % growth | 172M 8.04% | 176.97M | -4.97M | -2.81% |
| Q3 2022 Q2Q % growth | 167.5M 31.17% | 172.36M | -4.86M | -2.82% |
| Q2 2022 Q2Q % growth | 169.4M 24.93% | 173.71M | -4.31M | -2.48% |
| Q1 2022 Q2Q % growth | 158M 32.77% | 162.53M | -4.53M | -2.79% |
| Q4 2021 Q2Q % growth | 159.2M 21.53% | 159.54M | -340K | -0.21% |
| Q3 2021 Q2Q % growth | 127.7M 8.68% | 132.98M | -5.28M | -3.97% |
| Q2 2021 Q2Q % growth | 135.6M 79.60% | 134.58M | 1.02M | 0.76% |
| Q1 2021 Q2Q % growth | 119M 12.58% | 121.66M | -2.66M | -2.19% |
| Q4 2020 Q2Q % growth | 131M 7.03% | 134.2M | -3.2M | -2.38% |
| Q3 2020 Q2Q % growth | 117.5M 12.23% | 118.05M | -550K | -0.47% |
| Q2 2020 Q2Q % growth | 75.5M -26.41% | 73.906M | 1.594M | 2.16% |
| Q1 2020 Q2Q % growth | 105.7M 15.77% | 104.22M | 1.48M | 1.42% |
| Q4 2019 Q2Q % growth | 122.4M | 123.71M | -1.31M | -1.06% |
| Q3 2019 Q2Q % growth | 104.7M | 107.48M | -2.78M | -2.59% |
| Q2 2019 Q2Q % growth | 102.6M | 102.46M | 140K | 0.14% |
| Q1 2019 Q2Q % growth | 91.3M | 94.034M | -2.734M | -2.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.19% | 0.55% | 0.84% | -1.04% |
| Revenue | -0.56% | -1.23% | -0.08% | -0.59% |